Piramal Pharma's loss narrows to Rs82 crore in June quarter
Piramal Pharma Ltd will focus on increasing capacities for its contract development and manufacturing business, its largest revenue driver, even as it expects muted growth in 2025-26, chairperson Nandini Piramal said on Tuesday. The company is aiming to …